Suppression of Proliferation and Cardiomyocyte Hypertrophy by CHAMP, a Cardiac-specific RNA Helicase

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2002 Feb 21

PMID 11854500

Citations 24

Authors

Zhi-Ping Liu

Eric N Olson

Affiliations

Soon will be listed here.

Abstract

Adult cardiomyocytes are irreversibly postmitotic but respond to a variety of stimuli by hypertrophic growth, which is associated with an increase in cell size and protein content, organization of sarcomeres, and activation of a fetal gene program. Recently, we described a novel cardiac helicase activated by MEF2 protein (CHAMP), which is expressed specifically in the heart throughout prenatal and postnatal development. Here we show that CHAMP acts as an inhibitor of cell proliferation and cardiomyocyte hypertrophy. Ectopic expression of CHAMP inhibits proliferation of HeLa cells and blocks cell cycle entry of serum-stimulated NIH 3T3 cells. Overexpression of CHAMP in primary neonatal cardiomyocytes blocks hypertrophic growth and the induction of fetal genes in response to stimulation by serum and phenylephrine but does not prevent sarcomere organization or early mitogenic signaling events including activation of extracellular signal-regulated kinases or up-regulation of c-fos. Inhibition of cardiomyocyte hypertrophy by CHAMP requires the conserved ATPase domain and is accompanied by up-regulation of the cyclin-dependent protein kinase inhibitor p21(CIP1). These findings identify CHAMP as a cardiac-specific suppressor of cardiomyocyte hypertrophy and cell cycle progression and suggest that CHAMP may suppress these processes through the regulation of p21(CIP1).

Citing Articles

Adapting cytoskeleton-mitochondria patterning with myocyte differentiation by promyogenic PRR33.

Fu X, Zhang F, Dong X, Pu L, Feng Y, Xu Y Cell Death Differ. 2024; 32(1):177-193.

PMID: 39147882 PMC: 11742405. DOI: 10.1038/s41418-024-01363-w.

Right ventricular cardiomyocyte expansion accompanies cardiac regeneration in newborn mice after large left ventricular infarcts.

Hu T, Malek Mohammadi M, Ebach F, Hesse M, Kotlikoff M, Fleischmann B JCI Insight. 2024; 9(5).

PMID: 38319719 PMC: 11143925. DOI: 10.1172/jci.insight.176281.

Genetic Determinants of the Interventricular Septum Are Linked to Ventricular Septal Defects and Hypertrophic Cardiomyopathy.

Yu M, Harper A, Aguirre M, Pittman M, Tcheandjieu C, Amgalan D Circ Genom Precis Med. 2023; 16(3):207-215.

PMID: 37017090 PMC: 10293084. DOI: 10.1161/CIRCGEN.122.003708.

Matricellular Protein Cilp1 Promotes Myocardial Fibrosis in Response to Myocardial Infarction.

Zhang Q, He Y, Li Y, Shen H, Lin L, Zhu M Circ Res. 2021; 129(11):1021-1035.

PMID: 34610755 PMC: 8722455. DOI: 10.1161/CIRCRESAHA.121.319482.

The Role of Cell Cycle Regulators in Cell Survival-Dual Functions of Cyclin-Dependent Kinase 20 and p21.

Lai L, Shin G, Qiu H Int J Mol Sci. 2020; 21(22).

PMID: 33198081 PMC: 7698114. DOI: 10.3390/ijms21228504.

References

Kolodziejczyk S, Wang L, Balazsi K, DeRepentigny Y, Kothary R, Megeney L . MEF2 is upregulated during cardiac hypertrophy and is required for normal post-natal growth of the myocardium. Curr Biol. 1999; 9(20):1203-6. DOI: 10.1016/S0960-9822(00)80027-5. View

Hunter J, Chien K . Signaling pathways for cardiac hypertrophy and failure. N Engl J Med. 1999; 341(17):1276-83. DOI: 10.1056/NEJM199910213411706. View

Clerk A, Sugden P . Activation of protein kinase cascades in the heart by hypertrophic G protein-coupled receptor agonists. Am J Cardiol. 2000; 83(12A):64H-69H. DOI: 10.1016/s0002-9149(99)00261-1. View

Liu J, Shen X, Nguyen V, Kunos G, Gao B . Alpha(1) adrenergic agonist induction of p21(waf1/cip1) mRNA stability in transfected HepG2 cells correlates with the increased binding of an AU-rich element binding factor. J Biol Chem. 2000; 275(16):11846-51. DOI: 10.1074/jbc.275.16.11846. View

Passier R, Zeng H, Frey N, Naya F, Nicol R, McKinsey T . CaM kinase signaling induces cardiac hypertrophy and activates the MEF2 transcription factor in vivo. J Clin Invest. 2000; 105(10):1395-406. PMC: 315462. DOI: 10.1172/JCI8551. View

Olson E, Williams R . Calcineurin signaling and muscle remodeling. Cell. 2000; 101(7):689-92. DOI: 10.1016/s0092-8674(00)80880-6. View

Frey N, McKinsey T, Olson E . Decoding calcium signals involved in cardiac growth and function. Nat Med. 2000; 6(11):1221-7. DOI: 10.1038/81321. View

Frey N, Richardson J, Olson E . Calsarcins, a novel family of sarcomeric calcineurin-binding proteins. Proc Natl Acad Sci U S A. 2000; 97(26):14632-7. PMC: 18970. DOI: 10.1073/pnas.260501097. View

Leinwand L . Calcineurin inhibition and cardiac hypertrophy: a matter of balance. Proc Natl Acad Sci U S A. 2001; 98(6):2947-9. PMC: 33335. DOI: 10.1073/pnas.051033698. View

10.

Lim H, New L, Han J, Molkentin J . Calcineurin enhances MAPK phosphatase-1 expression and p38 MAPK inactivation in cardiac myocytes. J Biol Chem. 2001; 276(19):15913-9. DOI: 10.1074/jbc.M100452200. View

11.

Nicol R, Frey N, Pearson G, Cobb M, Richardson J, Olson E . Activated MEK5 induces serial assembly of sarcomeres and eccentric cardiac hypertrophy. EMBO J. 2001; 20(11):2757-67. PMC: 125475. DOI: 10.1093/emboj/20.11.2757. View

12.

Liu Z, Nakagawa O, Nakagawa M, Yanagisawa H, Passier R, Richardson J . CHAMP, a novel cardiac-specific helicase regulated by MEF2C. Dev Biol. 2001; 234(2):497-509. DOI: 10.1006/dbio.2001.0277. View

13.

NOZATO T, Ito H, Watanabe M, Ono Y, Adachi S, Tanaka H . Overexpression of cdk Inhibitor p16INK4a by adenovirus vector inhibits cardiac hypertrophy in vitro and in vivo: a novel strategy for the gene therapy of cardiac hypertrophy. J Mol Cell Cardiol. 2001; 33(8):1493-504. DOI: 10.1006/jmcc.2001.1412. View

14.

Tanner N, Linder P . DExD/H box RNA helicases: from generic motors to specific dissociation functions. Mol Cell. 2001; 8(2):251-62. DOI: 10.1016/s1097-2765(01)00329-x. View

15.

Martin J, Schwarz J, Olson E . Myocyte enhancer factor (MEF) 2C: a tissue-restricted member of the MEF-2 family of transcription factors. Proc Natl Acad Sci U S A. 1993; 90(11):5282-6. PMC: 46700. DOI: 10.1073/pnas.90.11.5282. View

16.

Edmondson D, Lyons G, Martin J, Olson E . Mef2 gene expression marks the cardiac and skeletal muscle lineages during mouse embryogenesis. Development. 1994; 120(5):1251-63. DOI: 10.1242/dev.120.5.1251. View

17.

Ishida N, Shirane M, Inomata A, Inoue T, Shishido N, HORII I . Mice lacking p27(Kip1) display increased body size, multiple organ hyperplasia, retinal dysplasia, and pituitary tumors. Cell. 1996; 85(5):707-20. DOI: 10.1016/s0092-8674(00)81237-4. View

18.

Kiyokawa H, Kineman R, Soares V, HOFFMAN E, Ono M, Khanam D . Enhanced growth of mice lacking the cyclin-dependent kinase inhibitor function of p27(Kip1). Cell. 1996; 85(5):721-32. DOI: 10.1016/s0092-8674(00)81238-6. View

19.

Fero M, Rivkin M, Tasch M, Porter P, Carow C, Firpo E . A syndrome of multiorgan hyperplasia with features of gigantism, tumorigenesis, and female sterility in p27(Kip1)-deficient mice. Cell. 1996; 85(5):733-44. DOI: 10.1016/s0092-8674(00)81239-8. View

20.

Weng Y, Czaplinski K, Peltz S . Genetic and biochemical characterization of mutations in the ATPase and helicase regions of the Upf1 protein. Mol Cell Biol. 1996; 16(10):5477-90. PMC: 231548. DOI: 10.1128/MCB.16.10.5477. View